1. Home
  2. IRIX

as of 02-06-2026 11:43am EST

$1.43
$0.00
0.00%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Founded: 1989 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 25.6M IPO Year: 1996
Target Price: N/A AVG Volume (30 days): 150.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.30 EPS Growth: N/A
52 Week Low/High: $0.78 - $1.70 Next Earning Date: 03-26-2026
Revenue: $50,647,000 Revenue Growth: 4.58%
Revenue Growth (this year): 9.61% Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: -3988000.0 FCF Growth: N/A

AI-Powered IRIX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 77.70%
77.70%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of IRIDEX Corporation (IRIX)

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Feb 3, 2026

Avg Cost/Share

$1.38

Shares

2,500

Total Value

$3,450.00

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 29, 2026

Avg Cost/Share

$1.44

Shares

1,101

Total Value

$1,587.64

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 28, 2026

Avg Cost/Share

$1.46

Shares

1,300

Total Value

$1,898.00

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 27, 2026

Avg Cost/Share

$1.48

Shares

3,385

Total Value

$5,009.46

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 26, 2026

Avg Cost/Share

$1.52

Shares

1,243

Total Value

$1,889.36

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 23, 2026

Avg Cost/Share

$1.48

Shares

5,221

Total Value

$7,716.12

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 21, 2026

Avg Cost/Share

$1.51

Shares

2,159

Total Value

$3,233.27

Owned After

115,190

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 20, 2026

Avg Cost/Share

$1.50

Shares

2,100

Total Value

$3,147.27

Owned After

115,190

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Jan 16, 2026

Avg Cost/Share

$1.42

Shares

3,496

Total Value

$5,006.31

Owned After

115,190

SEC Form 4

Buy
IRIX Dec 16, 2025

Avg Cost/Share

$1.01

Shares

2,000

Total Value

$2,019.80

Owned After

251,550

SEC Form 4

Latest IRIDEX Corporation News

IRIX Breaking Stock News: Dive into IRIX Ticker-Specific Updates for Smart Investing

All IRIX News

Share on Social Networks: